NETANYA, Israel, March 10, 2021 / PRNewswire / – Perflow Medical, an innovative privately held Israel- based neurovascular treatment solutions company, announced today that it has launched the Cascade ™ 17 non-occlusive remodeling network on the European market . Expanding the Cascade family of products, the Cascade 17 optimizes non-occlusive support of tortuous and distal vessel anatomy during coil embolization of smaller vessel intracranial aneurisms. The Cascade 17is the latest addition to Perflow’s portfolio of neurovascular devices based on a new proprietary technology platform, CEREBRAL NET ™, including the Stream ™ dynamic neuro-thromboectomy network (Stream Net). Early clinical experience with the Cascade 17 is extremely promising and further expands the range of cerebral vessels that can now be treated with Perflow’s unique CEREBRAL NET technology. The non-occlusive network design allows for continuous blood flow during cerebral aneurism repair and coil, which maintains adequate perfusion and can improve patient outcomes.
“La capacidad de realizar bobinas de aneurismo apoyadas por Cascade sin necesidad de utilizar un globo oclusivo o de colocar un stent en pacientes con aneurismos cerebrales proporciona a los médicos una oportunidad única para colocar de forma segura las bobinas embólicas en situaciones difíciles y ofrecer un tratamiento exitoso sin poner a los pacientes en medicación de por vida”, dijo el Dr. Xavier Barreau, Neurorradiólogo Intervencionista Senior del CHU de Burdeos , Unidad de Neurorradiología – Francia, que fue el primer médico en utilizar el Cascade17 clínicamente. “Después de una serie de tratamientos exitosos con Cascade Agile, recientemente comenzamos a usar el Cascade17 para tratar aneurismos en vasos más pequeños donde se prefiere el acceso a través de un microcatéter más delgado. El Cascade17 se podía navegar fácilmente a la anatomía distal, y la estructura trenzada de radiopaque proporcionaba un excelente soporte de bobina. Esperamos seguir usando este dispositivo único en nuestra práctica rutinaria.”
“We are excited to begin 2021 with the launch of the Cascade17,” said Danny Farin , CEO of Perflow Medical. “This important milestone builds on the success of the Cascade family of products and is the first of several exciting product announcements to come, including the Stream17 dynamic neuro-thromboectomy network, as well as other new products for different indications we’re in. currently working.”
The Cascade Net and Stream Net product families are commercially available throughout Europe for the treatment of intracranial aneurysms and acute ischemic strokes, respectively. Perflow products are not yet approved for clinical use within the United States.
About Perflow Medical
Perflow Medical, a private medical device company based in Israel, develops and manufactures innovative solutions to address complex neurovascular disorders. Perflow’s patent-protected CEREBRAL NET ™ technology platform, a braided network that enables adjustable neurovascular treatments, emphasizes the physician’s expertise by combining real-time medical monitoring, advanced device manipulation, complete wall apposition, and excellent radiopacity to improve patient outcomes. Its commercial product portfolio includes Stream ™ Net, devices for treating acute ischemic stroke, and Cascade ™ Net, devices for treating intracranial aneurysms. More information inwww.perflow.com .
Logo – https://mma.prnewswire.com/media/1453897/logo_perflow_gray_Logo.jpg
Related Links
SOURCE Perflow Medical
